Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Two cystic fibrosis transmembrane conductance regulator mutations have different effects on both pulmonary phenotype and regulation of outwardly rectified chloride currents.
Fulmer SB
,
Schwiebert EM
,
Morales MM
,
Guggino WB
,
Cutting GR
.
???displayArticle.abstract???
Cystic fibrosis (CF), a disorder of electrolyte transport manifest in the lungs, pancreas, sweat duct, and vas deferens, is caused by mutations in the CF transmembrane conductance regulator (CFTR). The CFTR protein has been shown to function as a cAMP-activated chloride channel and also regulates a separate protein, the outwardly rectifying chloride channel (ORCC). To determine the consequence of disease-producing mutations upon these functions, mutant CFTR was transiently expressed in Xenopus oocytes and in human airway epithelial cells lacking functional CFTR. Both G551D, a mutation that causes severe lung disease, and A455E, a mutation associated with mild lung disease, altered but did not abolish CFTR's function as a chloride channel in Xenopus oocytes. Airway epithelial cells transfected with CFTR bearing either A455E or G551D had levels of chloride conductance significantly greater than those of mock-transfected and lower than those of wild-type CFTR-transfected cells, as measured by chloride efflux. A combination of channel blockers and analysis of current-voltage relationships were used to dissect the contribution of CFTR and the ORCC to whole cell currents of transfected cells. While CFTR bearing either mutation could function as a chloride channel, only CFTR bearing A455E retained the function of regulating the ORCC. These results indicate that CF mutations can affect CFTR functions differently and suggest that severity of pulmonary disease may be more closely associated with the regulatory rather than chloride channel function of CFTR.
Anderson,
Demonstration that CFTR is a chloride channel by alteration of its anion selectivity.
1991, Pubmed
Anderson,
Demonstration that CFTR is a chloride channel by alteration of its anion selectivity.
1991,
Pubmed
Bear,
Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR).
1992,
Pubmed
Cheng,
Phosphorylation of the R domain by cAMP-dependent protein kinase regulates the CFTR chloride channel.
1991,
Pubmed
Drumm,
Chloride conductance expressed by delta F508 and other mutant CFTRs in Xenopus oocytes.
1991,
Pubmed
,
Xenbase
Egan,
Defective regulation of outwardly rectifying Cl- channels by protein kinase A corrected by insertion of CFTR.
1992,
Pubmed
Flotte,
Expression of the cystic fibrosis transmembrane conductance regulator from a novel adeno-associated virus promoter.
1993,
Pubmed
Gabriel,
CFTR and outward rectifying chloride channels are distinct proteins with a regulatory relationship.
1993,
Pubmed
Gan,
Correlation between genotype and phenotype in patients with cystic fibrosis.
1994,
Pubmed
Gregory,
Maturation and function of cystic fibrosis transmembrane conductance regulator variants bearing mutations in putative nucleotide-binding domains 1 and 2.
1991,
Pubmed
Grubb,
Hyperabsorption of Na+ and raised Ca(2+)-mediated Cl- secretion in nasal epithelia of CF mice.
1994,
Pubmed
Hamosh,
Cystic fibrosis patients bearing both the common missense mutation Gly----Asp at codon 551 and the delta F508 mutation are clinically indistinguishable from delta F508 homozygotes, except for decreased risk of meconium ileus.
1992,
Pubmed
Hwang,
Cl- channels in CF: lack of activation by protein kinase C and cAMP-dependent protein kinase.
1989,
Pubmed
Hyde,
Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport.
1990,
Pubmed
Johnson,
Normalization of raised sodium absorption and raised calcium-mediated chloride secretion by adenovirus-mediated expression of cystic fibrosis transmembrane conductance regulator in primary human cystic fibrosis airway epithelial cells.
1995,
Pubmed
Jovov,
Cystic fibrosis transmembrane conductance regulator is required for protein kinase A activation of an outwardly rectified anion channel purified from bovine tracheal epithelia.
1995,
Pubmed
Kartner,
Mislocalization of delta F508 CFTR in cystic fibrosis sweat gland.
1992,
Pubmed
Kerem,
Identification of the cystic fibrosis gene: genetic analysis.
1989,
Pubmed
Kunz,
The human leukocyte platelet-activating factor receptor. cDNA cloning, cell surface expression, and construction of a novel epitope-bearing analog.
1992,
Pubmed
Logan,
Cystic fibrosis transmembrane conductance regulator mutations that disrupt nucleotide binding.
1994,
Pubmed
Mittereder,
Evaluation of the efficacy and safety of in vitro, adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA.
1994,
Pubmed
Rich,
Effect of deleting the R domain on CFTR-generated chloride channels.
1991,
Pubmed
Riordan,
Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.
1989,
Pubmed
Rommens,
Identification of the cystic fibrosis gene: chromosome walking and jumping.
1989,
Pubmed
Schwiebert,
Both CFTR and outwardly rectifying chloride channels contribute to cAMP-stimulated whole cell chloride currents.
1994,
Pubmed
Sheppard,
Inhibition of the cystic fibrosis transmembrane conductance regulator by ATP-sensitive K+ channel regulators.
1993,
Pubmed
Sheppard,
Mechanism of dysfunction of two nucleotide binding domain mutations in cystic fibrosis transmembrane conductance regulator that are associated with pancreatic sufficiency.
1995,
Pubmed
Yang,
Molecular basis of defective anion transport in L cells expressing recombinant forms of CFTR.
1993,
Pubmed
